BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 34774223)

  • 1. Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study.
    Browne AJ; Chipeta MG; Haines-Woodhouse G; Kumaran EPA; Hamadani BHK; Zaraa S; Henry NJ; Deshpande A; Reiner RC; Day NPJ; Lopez AD; Dunachie S; Moore CE; Stergachis A; Hay SI; Dolecek C
    Lancet Planet Health; 2021 Dec; 5(12):e893-e904. PubMed ID: 34774223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
    Antimicrobial Resistance Collaborators
    Lancet; 2022 Feb; 399(10325):629-655. PubMed ID: 35065702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping local variation in household overcrowding across Africa from 2000 to 2018: a modelling study.
    Chipeta MG; Kumaran EPA; Browne AJ; Hamadani BHK; Haines-Woodhouse G; Sartorius B; Reiner RC; Dolecek C; Hay SI; Moore CE
    Lancet Planet Health; 2022 Aug; 6(8):e670-e681. PubMed ID: 35932787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014-2018: Findings and Implications from ESAC-Net and WHO Europe.
    Robertson J; Vlahović-Palčevski V; Iwamoto K; Högberg LD; Godman B; Monnet DL; Garner S; Weist K; ;
    Front Pharmacol; 2021; 12():639207. PubMed ID: 34220495
    [No Abstract]   [Full Text] [Related]  

  • 5. The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.
    Antimicrobial Resistance Collaborators
    Lancet Glob Health; 2024 Feb; 12(2):e201-e216. PubMed ID: 38134946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000-17.
    Local Burden of Disease Diarrhoea Collaborators
    Lancet Glob Health; 2020 Aug; 8(8):e1038-e1060. PubMed ID: 32710861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015.
    Klein EY; Van Boeckel TP; Martinez EM; Pant S; Gandra S; Levin SA; Goossens H; Laxminarayan R
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3463-E3470. PubMed ID: 29581252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis.
    Antimicrobial Resistance Collaborators
    Lancet Reg Health Am; 2023 Sep; 25():100561. PubMed ID: 37727594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic medicine consumption in 65 countries and regions, 2008-19: a longitudinal study.
    Brauer R; Alfageh B; Blais JE; Chan EW; Chui CSL; Hayes JF; Man KKC; Lau WCY; Yan VKC; Beykloo MY; Wang Z; Wei L; Wong ICK
    Lancet Psychiatry; 2021 Dec; 8(12):1071-1082. PubMed ID: 34801129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community level antibiotic utilization in India and its comparison vis-à-vis European countries: Evidence from pharmaceutical sales data.
    Farooqui HH; Selvaraj S; Mehta A; Heymann DL
    PLoS One; 2018; 13(10):e0204805. PubMed ID: 30332450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in reported antibiotic use among children under 5 years of age with fever, diarrhoea, or cough with fast or difficult breathing across low-income and middle-income countries in 2005-17: a systematic analysis of 132 national surveys from 73 countries.
    Allwell-Brown G; Hussain-Alkhateeb L; Kitutu FE; Strömdahl S; Mårtensson A; Johansson EW
    Lancet Glob Health; 2020 Jun; 8(6):e799-e807. PubMed ID: 32446345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000-17.
    Local Burden of Disease WaSH Collaborators
    Lancet Glob Health; 2020 Sep; 8(9):e1162-e1185. PubMed ID: 32827479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic exposure among children younger than 5 years in low-income and middle-income countries: a cross-sectional study of nationally representative facility-based and household-based surveys.
    Fink G; D'Acremont V; Leslie HH; Cohen J
    Lancet Infect Dis; 2020 Feb; 20(2):179-187. PubMed ID: 31843383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants.
    NCD Risk Factor Collaboration (NCD-RisC)
    Lancet; 2017 Jan; 389(10064):37-55. PubMed ID: 27863813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries.
    Hsia Y; Sharland M; Jackson C; Wong ICK; Magrini N; Bielicki JA
    Lancet Infect Dis; 2019 Jan; 19(1):67-75. PubMed ID: 30522834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of trends in reported antibiotic use among sick children under five years of age across low-income and middle-income countries in 2005-17: A systematic analysis of user characteristics based on 132 national surveys from 73 countries.
    Allwell-Brown G; Hussain-Alkhateeb L; Sewe MO; Kitutu FE; Strömdahl S; Mårtensson A; Johansson EW
    Int J Infect Dis; 2021 Jul; 108():473-482. PubMed ID: 34058373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Gastro-oesophageal Reflux Disease Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):561-581. PubMed ID: 32178772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants.
    Danaei G; Finucane MM; Lin JK; Singh GM; Paciorek CJ; Cowan MJ; Farzadfar F; Stevens GA; Lim SS; Riley LM; Ezzati M;
    Lancet; 2011 Feb; 377(9765):568-77. PubMed ID: 21295844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Medicines Consumption in Eastern Europeand Central Asia - An Updated Cross-National Study and Assessment of QuantitativeMetrics for Policy Action.
    Robertson J; Iwamoto K; Hoxha I; Ghazaryan L; Abilova V; Cvijanovic A; Pyshnik H; Darakhvelidze M; Makalkina L; Jakupi A; Dzhakubekova A; Carp A; Cizmovic L; Rachina S; Radonjic V; Yusufi S; Aksoy M; Ibragimova M; Godman B; Kluge H; Pedersen HB
    Front Pharmacol; 2018; 9():1156. PubMed ID: 30890943
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data.
    Klein EY; Milkowska-Shibata M; Tseng KK; Sharland M; Gandra S; Pulcini C; Laxminarayan R
    Lancet Infect Dis; 2021 Jan; 21(1):107-115. PubMed ID: 32717205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.